Crossref

1. Pharmacological Profile of Novel Anti-cancer Drugs Approved by USFDA in 2022: A Review

- Kavita Sangwan

- Vipasha Sharma

- Parveen Kumar Goyal

2. Pharmacological Profile of FDA-Approved Orphan Drugs in the Year 2022

- Parveen Kumar Goyal

- Kavita Sangwan

3. Current landscape of innovative drug development and regulatory support in China

- Ruirong Tan

- Hua Hua

- Siyuan Zhou

- Zhimin Yang

- Changming Yang

- Guo Huang

- Jin Zeng

- Junning Zhao